Suppr超能文献

大麻素受体激活通过激活人突触中的突触蛋白,急性增加突触囊泡数量。

Cannabinoid receptor activation acutely increases synaptic vesicle numbers by activating synapsins in human synapses.

机构信息

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA, 94305, USA.

Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 109A Galvin Life Science Center, Notre Dame, IN, 46556, USA.

出版信息

Mol Psychiatry. 2021 Nov;26(11):6253-6268. doi: 10.1038/s41380-021-01095-0. Epub 2021 Apr 30.

Abstract

Cannabis and cannabinoid drugs are central agents that are used widely recreationally and are employed broadly for treating psychiatric conditions. Cannabinoids primarily act by stimulating presynaptic CB1 receptors (CB1Rs), the most abundant G-protein-coupled receptors in brain. CB1R activation decreases neurotransmitter release by inhibiting presynaptic Ca channels and induces long-term plasticity by decreasing cellular cAMP levels. Here we identified an unanticipated additional mechanism of acute cannabinoid signaling in presynaptic terminals that regulates the size of synaptic vesicle pools available for neurotransmitter release. Specifically, we show that activation of CB1Rs in human and mouse neurons rapidly recruits vesicles to nerve terminals by suppressing the cAMP-dependent phosphorylation of synapsins. We confirmed this unanticipated mechanism using conditional deletion of synapsin-1, the predominant synapsin isoform in human neurons, demonstrating that synapsin-1 significantly contributes to the CB1R-dependent regulation of neurotransmission. Interestingly, acute activation of the Gi-DREADD hM4D mimics the effect of CB1R activation in a synapsin-1-dependent manner, suggesting that the control of synaptic vesicle numbers by synapsin-1 phosphorylation is a general presynaptic mechanism of neuromodulation. Thus, we uncovered a CB1R-dependent presynaptic mechanism that rapidly regulates the organization and neurotransmitter release properties of synapses.

摘要

大麻和大麻素类药物是中枢性药物,被广泛地用作娱乐性药物,并且广泛用于治疗精神疾病。大麻素类药物主要通过刺激突触前 CB1 受体 (CB1Rs) 起作用,CB1Rs 是大脑中最丰富的 G 蛋白偶联受体。CB1R 的激活通过抑制突触前 Ca 通道减少神经递质释放,并通过降低细胞 cAMP 水平诱导长期可塑性。在这里,我们在突触前末梢中鉴定出一种意想不到的急性大麻素信号转导的附加机制,该机制调节可用于神经递质释放的突触小泡池的大小。具体而言,我们表明,CB1R 在人类和小鼠神经元中的激活通过抑制 cAMP 依赖性突触丝蛋白磷酸化来快速将囊泡募集到神经末梢。我们使用突触丝蛋白-1 的条件性缺失证实了这种意外的机制,突触丝蛋白-1 是人类神经元中主要的突触丝同工型,证明突触丝蛋白-1 显著有助于 CB1R 依赖性神经传递的调节。有趣的是,Gi-DREADD hM4D 的急性激活以依赖于突触丝蛋白-1 的方式模拟 CB1R 激活的效果,表明突触小泡数量受突触丝蛋白磷酸化的控制是神经调节的一般突触前机制。因此,我们发现了一种依赖于 CB1R 的突触前机制,该机制可快速调节突触的组织和神经递质释放特性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验